DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Chouinard G, Saxena BM, Nair NPV et al.
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression.
J Affect Disord 1994;
32: 105-114
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.